Autoimmune Diseases  >>  CCX354  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CCX354 / Amgen
CARAT-2, NCT01242917 / 2010-019964-36: A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy

Checkmark Data - EULAR 2012
Jun 2012 - Jun 2012: Data - EULAR 2012
Checkmark Data
May 2012 - May 2012: Data
Checkmark Data
More
Completed
2
159
Europe, RoW
CCX-354-C, Placebo, CCX354-C
ChemoCentryx
Rheumatoid Arthritis
07/11
07/11
CARAT-1, NCT01027728: Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis

Completed
1/2
24
Europe
CCX 354-C
ChemoCentryx
Rheumatoid Arthritis
07/10
07/10

Download Options